Not applicable

Mechanism of Action

This product is a 3 ml vial designed for use with insulin pens to enable precise and sterile administration of peptides. It does not have a biochemical mechanism of action as it is a delivery device rather than a peptide or drug.

Reported Research Benefits

Used for the precise dosing and administration of research peptides such as BPC-157 in laboratory and research settings. Suitable for research applications requiring single-use sterile vials compatible with insulin pens.

Dosing Protocol & Reconstitution

Not applicable; the vial is a container for peptide delivery rather than a therapeutic agent needing dosing protocols.

Research Notes

Designed for single-use to maintain sterility and accuracy in dosing peptides during laboratory research. Compatible with 4 mm insulin pen needles. Ideal for peptides like BPC-157 in research contexts to ensure hygiene and precise dose measurement.

Research Summary

This product is a 3 ml vial intended for use with insulin pens to facilitate accurate and sterile administration of peptides and other injectable medications. While it is not a peptide itself and lacks a direct biochemical mechanism of action, studies on insulin pen delivery systems demonstrate enhanced dosing precision, improved patient adherence, and reduced risk of contamination compared to traditional syringes. Evidence primarily stems from clinical trials evaluating delivery device safety and efficacy rather than pharmacodynamic effects of the vial itself. Limitations include the absence of inherent pharmacological activity and reliance on the insulin pen system’s technology.

Side Effects & Safety

As a delivery device component rather than a pharmacologically active agent, this vial does not cause direct side effects. However, safety considerations include ensuring strict aseptic technique to prevent injection site infections or contamination. Any adverse reactions are typically related to the medication delivered using the insulin pen and not the vial itself. There are no known drug interactions or systemic effects from the vial material. It is not listed on any doping or banned substance lists such as WADA. Proper storage and handling per manufacturer guidelines are essential to maintain sterility and product integrity.

Stability & Storage

Refer to research notes

Molecular Data

Primary literature: https://pubmed.ncbi.nlm.nih.gov/?term=insulin+pen+delivery+devices